Genezen is a Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO) specialising in cell and gene therapy. Founded in Indianapolis in 2014, Genezen is focused on supporting the demands of the current and future gene and cell therapy manufacturing market worldwide, making viral vector production accessible to both early-stage, growth-oriented companies and established industry leaders. The company offers a range of services including early-phase process development, GMP lentiviral vector production, retroviral vector production, and analytical testing services, leveraging its extensive knowledge and experience in the industry and collaborating with leading institutions across the nation.

Services include:
– Regulatory Services
– Cell and Gene Therapy
– Injectables
– Analytical Services
– GMP Lentiviral Vector Production
– Retroviral Vector Production
– Early-Phase Process Development
– Analytical Testing Services

Genezen is committed to advancing the field of gene and cell therapy manufacturing, providing comprehensive solutions to meet the needs of its clients. For more information, please visit genezen.com.